Showing results (191-200 of 301) with videos related to
Sort By:
Pageof 31
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal originManuel J Koppe, Robert P Bleichrodt, Annemieke C Soede, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2005
Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposesFrank G van Schaijk, Otto C Boerman, Annemieke C Soede, et al.Blood|January 25, 2012
Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomasPankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.Oncotarget|November 16, 2020
Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancerThomas M Cardillo, Diane L Rossi, Maria B Zalath, et al.Arthritis Research & Therapy|March 13, 2012
The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expressionDaniela Frölich, Daniela Blassfeld, Karin Reiter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methodsRobert M Sharkey, Habibe Karacay, Thomas M Cardillo, et al.Methods (San Diego, Calif.)|April 26, 2005
Development of humanized antibodies as cancer therapeuticsZhengxing Qu, Gary L Griffiths, William A Wegener, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2005
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibodyEric Mirallié, Catherine Saï-Maurel, Alain Faivre-Chauvet, et al.Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargetingHåkan Hall, Irina Velikyan, Elisabeth Blom, et al.Pageof 31